Benign Gland Tumors
Benign Gland Tumors - Related Videos
07:23
A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster
0 Views •
Cited by 5 •
2013
Cooperation between an activated oncogene like RASV12 and mutations in cell polarity genes like scribbled, result in tumor growth in Drosophila where tumor cells also display invasive behaviors. Here a simple protocol for the induction and observation of the benign and invasive tumors is presented.
05:11
Treatment of Middle-segment Pancreatic Benign Tumor Using Laparoscopic Central Pancreatectomy with End-to-end Pancreatic Duct Reconstruction
0 Views •
2026
This article presents laparoscopic central pancreatectomy with pancreatic duct end-to-end anastomosis as an important surgical approach for middle-segment pancreatic benign and low-grade malignant tumors.
02:20
Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors
0 Views •
2024
The present protocol describes the application of mid-pancreatectomy combined with end-to-end anastomosis in the surgical treatment of pancreatic benign tumors, which presents a feasible solution for managing such tumors while concurrently preserving pancreatic function.
04:04
Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection
0 Views •
Cited by 1 •
2025
Here, we present a protocol to resect benign infratemporal fossa tumors via an endoscopic-assisted transoral lateral molar approach with low-temperature plasma ablation and intraoperative mandibular nerve monitoring. This minimally invasive technique prioritizes anatomical preservation, functional recovery, and avoidance of external scarring, demonstrating feasibility for well-demarcated lesions ≤4 cm in diameter.
03:37
Application of Robot-assisted Pancreaticobiliary Junction Resection in Benign Duodenal Tumors
0 Views •
2024
The current protocol delineates the use of robot-assisted pancreaticobiliary junction resection for the surgical management of benign duodenal tumors. This approach provides an effective solution for treating these tumors while minimizing duodenal loss and reducing associated complications.
FAQs
Genetic or signaling disruptions can weaken the normal controls that coordinate glandular epithelial cell division. When affected cells continue proliferating, their descendants form a related cellular population rather than an independent collection of changes. This mechanism makes benign gland tumors useful for examining how altered growth regulation produces a localized lesion before invasive or metastatic behavior appears.
Researchers distinguish these lesions from malignant disease by examining biological behavior and tissue organization. A benign growth generally remains well circumscribed, preserves some organized glandular features, and lacks invasion into nearby structures or spread to distant sites. These criteria matter because cell proliferation alone does not establish cancer; the pattern and consequences of growth also guide interpretation.
Clonal growth provides a way to connect an initiating alteration with the expanding tumor population. By studying the resulting mass, investigators can ask which genetic or signaling changes accompany abnormal proliferation and which remain compatible with localized growth. This comparison helps define early events in tumor development and identify changes that may be associated with later malignant progression.
Monitoring or removal may be considered when a lesion’s location or secretory activity produces clinical symptoms. The decision is therefore not based only on malignant potential: a noncancerous growth can still affect the patient because of where it arises or because it produces hormones or other secretions. These features provide the clinical context for management.
As research models, benign gland tumors allow investigators to study abnormal proliferation in a localized setting. Their analysis can reveal early growth mechanisms, support the search for diagnostic markers, and provide a comparison point for changes linked with progression toward malignancy. This makes them relevant to cancer research even when the tumors themselves do not behave as cancers.
Examination can help separate localized disease from cancer by combining structural and biological observations. Investigators can assess whether the growth retains organized tissue features, remains circumscribed, and shows no invasion or metastasis, while also considering genetic or signaling changes. The resulting information supports diagnostic interpretation and research into how malignant characteristics emerge.